A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma

Author： Hussain Maha   Daignault Stephanie   Agarwal Neeraj   Grivas Petros D.   Siefker-Radtke Arlene O.   Puzanov Igor   MacVicar Gary R.   Levine Ellis Glenn   Srinivas Sandy   Twardowski Przemyslaw   Eisenberger Mario A.   Quinn David I.   Vaishampayan Ulka N.   Yu Evan Y.   Dawsey Scott   Day Kathleen C.   Day Mark L.   Al-Hawary Mahmoud   Smith David C.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|17|2684-2693

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.17, 2014-09, pp. : 2684-2693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

BA11: Randomised Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients with Metastatic or Locally Advanced Urothelial Cancer without Prior Systemic Therapy*

By  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 55-56

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

By Vansteenkiste Johan   Canon Jean-Luc   Riska Henrik   Pirker Robert   Peterson Patrick   John William   Mali Pekka   Lahn Michael  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 263-269

Springer Publishing Company

Access to resources Recommend Favorite

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

Blackwell Publishing

Access to resources Recommend Favorite

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

By Nogueira-Rodrigues Angelica   Moralez Giulliana   Grazziotin Rachele   Carmo Claudio C.   Small Isabele A.   Alves Flavia V.G.   Mamede Marcelo   Erlich Felipe   Viegas Celia   Triginelli Sergio A.   Ferreira Carlos G.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1187-1193

Blackwell Publishing

Access to resources Recommend Favorite

An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

By Stadler Walter M.   Vaughn David J.   Sonpavde Guru   Vogelzang Nicholas J.   Tagawa Scott T.   Petrylak Daniel P.   Rosen Peter   Lin Chia-Chi   Mahoney John   Modi Sanjiv   Lee Peter   Ernstoff Marc S.   Su Wu-Chou   Spira Alexander   Pilz Korinna   Vinisko Richard   Schloss Charles   Fritsch Holger   Zhao Charles   Carducci Michael A.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 976-982

Blackwell Publishing

Access to resources Recommend Favorite